WHAT TO EXPECT FROM A PHENYTOIN DRUG-DRUG INTERACTION STUDY: ADVERSE EVENT PROFILING AND SAFETY ASSESSMENT

被引：0
|
作者：
Paglialunga, S. [1 ]
van Haarst, A. [2 ]
机构：
[1] Celerion, Tempe, AZ USA
[2] Celerion, Belfast, Antrim, North Ireland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-032
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database
    R. Leone
    U. Moretti
    A. Conforti
    L. Magro
    M. Moschini
    M. Tuccori
    P. Cutroneo
    D. Motola
    G. P. Velo
    Drug Safety, 2008, 31 : 885 - 885
  • [32] Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study
    Moreno, Irene
    Hernandez, Tatiana
    Calvo, Emiliano
    Fudio, Salvador
    Kahatt, Carmen
    Martinez, Sara
    Iglesias, Jorge Luis
    Calafati, Roman Octavio
    Perez-Ramos, Laura
    Montilla, Lola
    Zeaiter, Ali
    Lubomirov, Rubin
    MARINE DRUGS, 2024, 22 (04)
  • [33] Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
    Letinier, Louis
    Cossin, Sebastien
    Mansiaux, Yohann
    Arnaud, Mickael
    Salvo, Francesco
    Bezin, Julien
    Thiessard, Frantz
    Pariente, Antoine
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [34] STUDY OF IDENTIFICATION AND ASSESSMENT OF DRUG-DRUG INTERACTIONS
    Shekar, H. S.
    Chandrashekhar, H. R.
    Bhagawan, B. C.
    Alirezasahebdel
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (06): : 1373 - 1378
  • [35] Pharmacokinetics, Safety, and Tolerability of Etrasimod: Results From a Phase 1 Drug-Drug Interaction Study in Healthy Volunteers
    Lee, Caroline A.
    Tang, Yong
    Villa-Caballero, Leonel
    Shan, Kevin
    Randle, Andrenika
    Grundy, John S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S550 - S550
  • [36] In vivo assessment of inhibitory drug-drug interaction: A theoretical understanding
    Geng, WP
    DRUG METABOLISM REVIEWS, 2002, 34 : 130 - 130
  • [37] AN EXEMPLAR OF A SYSTEMS PHARMACOLOGY APPROACH FOR A DETAILED INVESTIGATION OF AN ADVERSE DRUG EVENT AS A RESULT OF DRUG-DRUG INTERACTIONS
    Kim, S.
    Lahu, G.
    Lesko, L. J.
    Trame, M. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S97 - S97
  • [38] STUDY FOR DRUG-DRUG INTERACTION IN THE TREATMENT OF CHRONIC DISEASE
    Chae, Jung-Woo
    Beak, Hyun-Moon
    Song, Byung-Jeong
    Lee, Byung-Yo
    Kang, Ho-Il
    Kwon, Kwang-Il
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E205 - E205
  • [39] Phenytoin/valproic-acidPhenytoin toxicity following drug-drug pharmacokinetic interaction: case report
    Reactions Weekly, 2021, 1880 (1) : 324 - 324
  • [40] Phenytoin/polyethylene-glycolVarious toxicities following drug-drug pharmacokinetic interaction: case report
    Reactions Weekly, 2025, 2052 (1) : 349 - 349
12345